NovoCure
NVCR
NVCR
166 hedge funds and large institutions have $1.94B invested in NovoCure in 2018 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 62 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 39
33% less capital invested
Capital invested by funds: $2.9B → $1.94B (-$955M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
166
Holding in Top 10
4
Calls
$31.4M
Puts
$4.54M
Top Buyers
| 1 | +$44.4M | |
| 2 | +$33.3M | |
| 3 | +$32.5M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$18.1M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$17.7M |
Top Sellers
| 1 | -$36.8M | |
| 2 | -$20.4M | |
| 3 | -$11.8M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.2M |
| 5 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
-$8.52M |